Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tecentriq
Biotech
Roche puts 'stronger gates' on ph. 3 pipeline to limit failures
Roche has installed “stronger gates” to ensure that drug candidates only make it into phase 3 trials if they have a high chance of success.
James Waldron
Sep 11, 2023 11:15am
Roche posts TIGIT survival data after 'inadvertent disclosure'
Aug 23, 2023 5:36am
PD-1 R&D tapers off as new molecules capture interest: IQVIA
May 24, 2023 2:09pm
Have mRNA cancer vaccines arrived? Biopharma execs weigh in
Jan 25, 2023 10:30am
Roche flunks phase 3 cancer test to leave TIGIT space reeling
May 11, 2022 3:32am
CytoDyn's shareholders have a plan to get leronlimab approved
Sep 24, 2021 11:37am
